Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder

British Journal of Psychiatry

Volumn 210, Issue 3, 2017, Pages 197-202

  Joas, Erik ^a   Karanti, Alina ^a   Song, Jie ^b   Goodwin, Guy M ^c   Lichtenstein, Paul ^b   Landén, Mikael ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; OLANZAPINE; QUETIAPINE; VALPROIC ACID; NEUROLEPTIC AGENT; TRANQUILIZER;

ARTICLE; BIPOLAR DISORDER; DEPRESSION; DRUG EFFICACY; HOSPITAL ADMISSION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MANIA; MENTAL HOSPITAL; MIXED MANIA AND DEPRESSION; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; PSYCHOPHARMACOTHERAPY; RECURRENCE RISK; REGISTER; RISK ASSESSMENT; SWEDEN; ADULT; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; RISK; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; RISK; SWEDEN;

EID: 85018779380     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.116.187989     Document Type: Article

References (29)

1. National Institute for Clinical Excellence (NICE). Bipolar Disorder: Assessment and Management. NICE, 2014 (https://www.nice.org.uk/guidance/cg185).
2. Miura T, Noma H, Furukawa T.A., Mitsuyasu H., Tanaka S, Stockton S, et al Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2014; 1: 351-9.
3. Goodwin FK, Jamison KR Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression: Bipolar Disorders and Recurrent Depression. Oxford University Press, 2007.
4. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005; 365: 82-93.
5. Licht R, Gouliaev G, Vestergaard P., Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264-7.
6. Tohen M, Greil W, Calabrese J.R., Sachs GS, Yatham LN, Oerlinghausen BM, et al Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005; 162: 1281-90.
7. Geddes JR, Goodwin GM, Rendell J, Azorin J-M, Cipriani A, Ostacher M.J., et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-95.
8. Licht RW, Nielsen JN, Gram L.F., Vestergaard P., Bendz H. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 2010; 12: 483-93.
9. Whitaker R, Cosgrove L. Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform. Palgrave Macmillan, 2015.
10. Kessing LV, Hellmund G, Geddes J.R., Goodwin GM, Andersen PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 2011; 199: 57-63.
11. Kessing LV, Hellmund G, Andersen PK An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol 2012; 26: 644-52.
12. Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry 2014; 75: 254-63.
13. Lichtenstein P, Halldner L, Zetterqvist J., Sjolander A, Serlachius E, Fazel S., et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 2012; 367: 2006-14.
14. Socialstyrelsen (The National Board of Health and Welfare). Uppgifter om Psykiatrisk vård i Patientregistret [Data on Psychiatric Care in the Patient Register]. Socialstyrelsen, 2014 (http://www.socialstyrelsen.se/publikationer2014/2014-2-14).
15. Karanti A, Bobeck C, Osterman M., Kardell M, Tidemalm D, Runeson B., et al. Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients. J Affect Disord 2015; 174: 303-9.
16. Sellgren C, Landen M, Lichtenstein P., Hultman CM, Langstrom N. Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand 2011; 124: 447-53.
17. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-8). WHO, 1967.
18. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO, 1978.
19. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
20. Fazel S, Zetterqvist J, Larsson H., Långstrom N, Lichtenstein P. Antipsychotics, mood stabilisers, and risk of violent crime. Lancet 2014; 384: 1206-14.
21. Molero Y, Lichtenstein P, Zetterqvist J., Gumpert CH, Fazel S. Selective serotonin reuptake inhibitors and violent crime: a cohort study. PLoS Med 2015; 12: e1001875.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
23. Leifeld P. texreg: Conversion of statistical model output in R to LATEX and HTML tables. J Stat Softw 2013; 55: 1-24.
24. Hayes JF, Marston L, Walters K., Geddes JR, King M, Osborn DPJ. Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. World Psychiatry 2016; 15: 53-8.
25. Vieta E, Günther O, Locklear J., Ekman M, Miltenburger C, Chatterton M.L., et al. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2011; 14: 1029-49.
26. Smith LA, Cornelius V, Warnock A., Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disorders 2007; 9: 394-412.
27. Deshauer D, Fergusson D, Duffy A., Albuquerque J, Grof P. Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. Bipolar Disord 2005; 7: 382-7.
28. Goodwin GM, Bowden CL, Calabrese J.R., Grunze H., Kasper S, White R, et al A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432-41.
29. Hirschfeld R, Kasper S. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol 2004; 7: 507-22.